Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of the disease across the world, drives the growth of the market David Correa Allied Market Research + 1 800-792-5285 ...
Probiotics may help with many health conditions. Although they're generally safe, it's important to talk with your doctor ...
1don MSN
Scientists say a groundbreaking new test can predict patients at high risk of developing bowel cancer with 90 per cent ...
The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.
Groundbreaking new test 90% accurate in finding patients at high risk of bowel cancer - Doctors believe new test could lead ...
Experts hope to create a blood test to see which patients with inflammatory bowel disease are most at risk of bowel cancer.
Coherus BioSciences, Inc.’s CHRS share price has surged by 10.66%, which has investors questioning if this is right time to sell.
Shares of Teva Pharmaceutical Industries ( TEVA -13.66%) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...
Research analysts at William Blair decreased their FY2025 earnings per share (EPS) estimates for shares of AbbVie in a note ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback